– USA, MA – Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies, research, and cell biology markets, today announced the appointment of Karen Firestone to its Board as an independent director, effective January 18, 2022.
“We are delighted to have Kari join our Board of Directors. As Hamilton Thorne continues to expand and evolve, it is important to add new voices and experience that will contribute to our development over the next decade. We look forward to Kari’s insights and support as Hamilton Thorne continues growing its business,” said CEO, David Wolf.
Ms. Firestone will also join the Audit Committee as Chair.
The Company also announced that Meg Spencer has retired as Chair of the Board of Directors. CEO, David Wolf will assume that position effective January 18, 2022.
In addition, the Company has named Feng Han to be the Chair of its Compensation Committee and Robert Potter to be the Chair of its Nominating and Governance Committee and its Lead Independent Director.
About Karen Firestone
Karen Firestone is co-founder, CEO, and Chair of Aureus Asset Management, a Boston, Massachusetts-based registered investment advisor. Previously, Kari worked for over two decades at Fidelity Investments. She was a portfolio manager of sector funds such as the Select Biotechnology, Health Care, Transportation, Media, and Leisure Funds. She also managed several diversified funds, including Destiny l, Large Cap Fund, and Advisor Large Cap Fund. For several years, Kari was responsible for all of the equity positions and decision-making in funds with collective assets of over $12 billion.
Kari is a contributor to CNBC, where she appears regularly on Squawk Box, Half Time Report, and other shows. She is also an author. Her book Even the Odds: Sensible Risk-Taking in Business, Investing, and Life offers a framework for risk-taking across a wide range of personal and professional experiences. She gave a TED talk about her book and also writes frequently for the Harvard Business Review and CNBC.com, about topics that range from executive decision-making, gender issues within companies, to who gets to play golf on a weekday afternoon.
Ms. Firestone previously served on the board of directors of Olivo Labs, a biotechnology/aesthetics company, until its purchase by Shisheido in 2018, and is currently a director of the Boys and Girls Clubs of Boston, where she is a member of the Finance Committee, and a trustee emerita at the Beth Israel Deaconess Medical Center, where she serves on several committees including the Compliance, Audit and Risk Committee. Kari received a Bachelor of Arts degree in Economics, magna cum laude, from Harvard College and an MBA from Harvard Business School.
About Hamilton Thorne Ltd.
Hamilton Thorne is a leading global provider of precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies, research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.
For more information: https://www.hamiltonthorne.ltd/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.